Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 23rd:
AmerisourceBergen Corporation : This provider of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
AmerisourceBergen Corporation Price and Consensus
AmerisourceBergen's shares gained 0.4% over the last one month compared to S&P 500’s fall of -2.9%. The company possesses a Momentum Score of B.
AmerisourceBergen Corporation Price
AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.4% over the last 60 days.
Aercap Holdings N.V. Price and Consensus
AerCap's shares gained 2.1% over the last one month. The company possesses a Momentum Score of B.
Aercap Holdings N.V. Price
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
ACADIA Pharmaceuticals Inc. Price and Consensus
ACADIA’s shares gained 33.1% over the last one month. The company possesses a Momentum Score of B.
ACADIA Pharmaceuticals Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 23rd:
AmerisourceBergen Corporation : This provider of pharmaceutical products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.2% over the last 60 days.
AmerisourceBergen Corporation Price and Consensus
AmerisourceBergen's shares gained 0.4% over the last one month compared to S&P 500’s fall of -2.9%. The company possesses a Momentum Score of B.
AmerisourceBergen Corporation Price
AerCap Holdings N.V. (AER - Free Report) : This aircraft leasing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.4% over the last 60 days.
Aercap Holdings N.V. Price and Consensus
AerCap's shares gained 2.1% over the last one month. The company possesses a Momentum Score of B.
Aercap Holdings N.V. Price
ACADIA Pharmaceuticals Inc. (ACAD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
ACADIA Pharmaceuticals Inc. Price and Consensus
ACADIA’s shares gained 33.1% over the last one month. The company possesses a Momentum Score of B.
ACADIA Pharmaceuticals Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on AER - FREE
Get the latest research report on ACAD - FREE